Intravenous immunoglobulin treatment in idiopathic inflammatory myopathy].
Levente Bodoki, Melinda Vincze, Zoltán Griger, Katalin Dankó
Debreceni Egyetem, Orvos- és Egészségtudományi Centrum, Általános Orvostudományi Kar Belgyógyászati Intézet, Klinikai Immunológiai Tanszék Debrecen Móricz Zsigmond krt. 22. 4032. bodoki.levente@gmail.com
Orvosi hetilap 2013 May 12Idiopathic inflammatory myopathies are chronic, systemic autoimmune diseases, characterized by symmetric and progressive weakness of proximal muscles in the upper and lower extremities. Treatment of the disease presents a complex challenge and it needs practical knowledge. In this review the authors summarize current treatment options, and discuss intravenous immunoglobulin treatment in therapy-unresponsive cases. Relevant data from the international literature is collected, too. Benefits and side effects of this treatment are also disclosed.
Citation
Levente Bodoki, Melinda Vincze, Zoltán Griger, Katalin Dankó. Intravenous immunoglobulin treatment in idiopathic inflammatory myopathy]. Orvosi hetilap. 2013 May 12;154(19):723-8
Mesh Tags
Substances
PMID: 23649636
View Full Text
